Source: International Congress 2017 – Hospital-acquired infections: from prevention to treatment
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Zuniga (Mexico City, Mexico). Circulating levels of miR-150 and miR-126 are associated with poor outcomes of influenza A/H1N1 virus infection.. 4654

Member's Comments

No comment yet.

Related content which might interest you: Cytokine response in pediatric patients with pandemic H1N1 influenza virus infection and pneumonia: Comparison with pediatric pneumonia without H1N1 infection Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection Year: 2011 Early diagnosis and causal treatment of pneumonia associated with pandemic influenza A (H1N1) virus Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Risk factors of fatal outcomes in influenza A/H1N1-09 viral infection Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011 Frequency and characteristics of prolonged viral shedding of influenza A/H1N1 virus in lung transplant recipients Source: Annual Congress 2011 - Lung transplantation Year: 2011 Long-term outcomes after viral pneumonia caused by influenza A (H1N1) Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011 Clarithromycin inhibits pandemic A/H1N1/2009 influenza virus infection in human airway epithelial cells Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Characteristics of patients diagnosed of influenza A virus (H1N1) infection in relation to service in charge Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology Year: 2010 Obesity as the most considerable risk factor for death due to influenza A/H1N1-09 viral infection Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Characteristics and outcome of pneumonia in patients with 2009 pandemic influenza A/H1N1. Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010 Predictors of H1N1 severe infection Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010 Socioeconomic correlates of SARS-CoV-2 and influenza H1N1 outbreaks Source: Eur Respir J, 56 (3) 2001400; 10.1183/13993003.01400-2020 Year: 2020 Influenza type A outbreak associated with myositis Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005 Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1 Source: Eur Respir J 2011; 38: 739-742 Year: 2011 Endothelial damage markers in patients with pandemic influenza A (H1N1/09) Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Assessing the potential pandemic risk of recent avian influenza viruses Source: Eur Respir J , 49 (3) 1602517; DOI: 10.1183/13993003.02517-2016 Year: 2017 Pneumonia and pandemic influenza virus A (H1N1/09). Immediate and remote results Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011 Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 The relation of people to vaccination against an influenza virus Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Arterial hypoxemia and diminished immune response at admission predict poor outcome in patients with viral-bacterial pneumonia during flu H1N1 pandemic period Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Avian influenza and SARS – how much of a threat is it to humans and what can be done to prevent this? Source: Annual Congress 2005 - Major viral threats to the lung Year: 2005